MARKET

KLDO

KLDO

Kaleido Biosciences
EXMKT
0.0001
0.0000
0.00%
Closed 10:03 01/16 EST
OPEN
0.0001
PREV CLOSE
0.0001
HIGH
0.0001
LOW
0.0001
VOLUME
100
TURNOVER
0
52 WEEK HIGH
0.190
52 WEEK LOW
0.0001
MARKET CAP
4.26K
P/E (TTM)
-0.0000
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at KLDO last week (0112-0116)?
Weekly Report · 9h ago
Weekly Report: what happened at KLDO last week (0105-0109)?
Weekly Report · 01/12 09:44
Weekly Report: what happened at KLDO last week (1229-0102)?
Weekly Report · 01/05 09:41
Weekly Report: what happened at KLDO last week (1222-1226)?
Weekly Report · 12/29/2025 09:40
Weekly Report: what happened at KLDO last week (1215-1219)?
Weekly Report · 12/22/2025 09:40
Weekly Report: what happened at KLDO last week (1208-1212)?
Weekly Report · 12/15/2025 09:44
Weekly Report: what happened at KLDO last week (1201-1205)?
Weekly Report · 12/08/2025 09:43
Weekly Report: what happened at KLDO last week (1124-1128)?
Weekly Report · 12/01/2025 09:41
More
About KLDO
Kaleido Biosciences, Inc. is a clinical-stage healthcare company focused on microbiome organs to treat disease and improve human health. The Company’s product candidates are Microbiome Metabolic Therapies (MMTs), which are designed to modulate the metabolic output and profile of the microbiome by driving the function and composition of existing microbes. It is advancing a pipeline of MMT candidates to address a range of diseases and conditions with unmet patient needs. KB109 and KB174 are the MMT candidates for development for the prevention of infections caused by multi-drug resistant (MDR) bacteria. The nomination of these candidates resulted from their performance relative to a range of other MMTs in ex vivo screening of microbiome samples from healthy volunteers as well as microbiome samples from intensive care unit patients in an experimental set-up that specifically focused on determining the potential of MMTs to decrease the relative abundance of a panel of pathogenic bacteria.

Webull offers Kaleido Biosciences Inc stock information, including EXMKT: KLDO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KLDO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KLDO stock methods without spending real money on the virtual paper trading platform.